Skip to content
Inhalation Capsule Allopathic

Seebri Breezhaler 50 mcg inhalation capsule

Generic: Glycopyrronium Bromide (Inhalation capsule)

Company: Nevian Lifescience PLC. Prices are as listed on BestinMeds; your pharmacy price may differ.

Strength50 mcg
PackBox of 30: 2996.31 taka

Reviewed by: not listed yet. Source: not listed yet.

Last updated September 7, 2024.

Compare

Same generic, same strength

Sorted by price per inhalation capsule. Ask your pharmacist before you switch brands.

Glycopyrronium Bromide (Inhalation capsule) 50 mcg inhalation capsules

Prices as listed on BestinMeds.

2 brands listed
Supotaria, box of 3020.00 taka per inhalation capsule
Seebri Breezhaler, box of 30 (this medicine)99.88 taka per inhalation capsule

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250
Medicine guide

About this medicine

What this medicine is for, how to take it, and what to watch for.

Read the full Glycopyrronium Bromide (Inhalation capsule) guide

Indications

Emphysema Maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

Dosage and administration

The recommended dosage of Glycopyrronium is the inhalation of the contents of one capsule once daily with the ConviHaler device at the same time of day.

Side effects

Inhaled medicines may cause inhalation-induced bronchospasm, dehydration, dry mouth, constipation, dizziness, insomnia, skin and subcutaneous tissue disorders, immune system disorders.

Precautions and warnings

Glycopyrronium, as a once-daily maintenance bronchodilator, should not be used for the initial treatment of acute episodes of bronchospasm, i.e. rescue therapy. Immediate hypersensitivity reactions may occur after administration of Glycopyrronium inhalation powder. As with other anticholinergic drugs, Glycopyrronium should be used with caution in patients with narrow-angle glaucoma, prostatic hyperplasia or bladder-neck obstruction.

Pregnancy and lactation

There is a limited amount of data from the use of Glycopyrronium in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity at clinically relevant doses. Glycopyrronium should not be used in pregnant or nursing women unless the expected benefit outweighs any possible risk to the unborn child or the infant.

Clinical details

BestinMeds shares medicine information to help you compare. It does not replace advice from your doctor or pharmacist.

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250

Advertisement

Google Ads 970 x 250
Google Ads 300 x 250